Quantification of visual field loss in age-related macular degeneration

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Acton, Jennifer H ^a,b   Gibson, Jonathan M ^b,c   Cubbidge, Robert P ^b  

^a NEW YORK UNIVERSITY   (United States)

^b ASTON UNIVERSITY   (United Kingdom)

^c CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMD SEVERITY INDEX; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; HUMAN; MALE; PERIMETRY; POST HOC ANALYSIS; RETINA MACULA AGE RELATED DEGENERATION; SENSITIVITY ANALYSIS; SHORT WAVELENGTH AUTOMATED PERIMETRY; STANDARD AUTOMATED PERIMETRY; VISUAL FIELD DEFECT;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84863098848     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039944     Document Type: Article

References (45)

1. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, et al. (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82: 844-851.
2. Rein DB, Wittenborn JS, Zhang X, Honeycutt AA, Lesesne SB, et al. (2009) Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol 127: 533-540.
3. Midena E, Degli Angeli C, Blarzino MC, Valenti M, Segato T, (1997) Macular function impairment in eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci 38: 469-477.
4. Midena E, Segato T, Blarzino MC, Degli Angeli C, (1994) Macular drusen and the sensitivity of the central visual field. Doc Ophthalmol 88: 179-185.
5. Remky A, Elsner AE, (2005) Blue on yellow perimetry with scanning laser ophthalmoscopy in patients with age related macular disease. Br J Ophthalmol 89: 464-469.
6. Remky A, Lichtenberg K, Elsner AE, Arend O, (2001) Short wavelength automated perimetry in age related maculopathy. Br J Ophthalmol 85: 1432-1436.
7. Tolentino MJ, Miller S, Gaudio AR, Sandberg MA, (1994) Visual field deficits in early age-related macular degeneration. Vision Res 34: 409-413.
8. Atchison DA, Lovie-Kitchin JE, Swann PG, (1990) Investigation of central visual fields in patients with age-related macular changes. Optom Vis Sci 67: 179-183.
9. Cheng AS, Vingrys AJ, (1993) Visual losses in early age-related maculopathy. Optom Vis Sci 70: 89-96.
10. Frennesson C, Nilsson UL, Nilsson SE, (1995) Colour contrast sensitivity in patients with soft drusen, an early stage of ARM. Doc Ophthalmol 90: 377-386.
11. Feigl B, Brown B, Lovie-Kitchin J, Swann P, (2005) Monitoring retinal function in early age-related maculopathy: visual performance after 1 year. Eye (Lond) 19: 1169-1177.
12. Mayer MJ, Spiegler SJ, Ward B, Glucs A, Kim CBY, (1992) Mid-Frequency Loss of Foveal Flicker Sensitivity in Early Stages of Age-Related Maculopathy. Investigative Ophthalmology & Visual Science 33: 3136-3142.
13. Phipps JA, Dang TM, Vingrys AJ, Guymer RH, (2004) Flicker perimetry losses in age-related macular degeneration. Investigative Ophthalmology & Visual Science 45: 3355-3360.
14. Owsley C, Jackson GR, Cideciyan AV, Huang YJ, Fine SL, et al. (2000) Psychophysical evidence for rod vulnerability in age-related macular degeneration. Investigative Ophthalmology & Visual Science 41: 267-273.
15. Scholl HPN, Bellmann C, Dandekar SS, Bird AC, Fitzke FW, (2004) Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy. Investigative Ophthalmology & Visual Science 45: 574-583.
16. Steinmetz RL, Haimovici R, Jubb C, Fitzke FW, Bird AC, (1993) Symptomatic Abnormalities of Dark-Adaptation in Patients with Age-Related Bruchs Membrane Change. Br J Ophthalmol 77: 549-554.
17. Gerth C, Hauser D, Delahunt PB, Morse LS, Werner JS, (2003) Assessment of multifocal electroretinogram abnormalities and their relation to morphologic characteristics in patients with large drusen. Arch Ophthalmol 121: 1404-1414.
18. Li J, Tso MOM, Lam TT, (2001) Reduced amplitude and delayed latency in foveal response of multifocal electroretinogram in early age related macular degeneration. Br J Ophthalmol 85: 287-290.
19. Goldstein M, Loewenstein A, Barak A, Baruch E, Feitt N, et al. (2005) Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration. Retina 25: 296-303.
20. Applegate RA, Adams AJ, Cavender JC, Zisman F, (1987) Early color vision changes in age-related maculopathy. Appl Opt 26: 1458-1462.
21. Eisner A, Fleming SA, Klein ML, Mauldin WM, (1987) Sensitivities in Older Eyes with Good Acuity - Eyes Whose Fellow Eye Has Exudative AMD. Invest Ophthalmol Vis Sci 28: 1832-1837.
22. Haegerstrom-Portnoy G, Brown B, (1989) 2-Color Increment Thresholds in Early Age-Related Maculopathy. Clin Vis Sci 4: 165-172.
23. Bengtsson B, Heijl A, Agardh E, (2005) Visual fields correlate better than visual acuity to severity of diabetic retinopathy. Diabetologia 48: 2494-2500.
24. Johnson CA, Adams AJ, Casson EJ, Brandt JD, (1993) Progression of early glaucomatous visual field loss as detected by blue-on-yellow and standard white-on-white automated perimetry. Arch Ophthalmol 111: 651-656.
25. Johnson CA, Adams AJ, Casson EJ, Brandt JD, (1993) Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss. Arch Ophthalmol 111: 645-650.
26. Wild JM, Cubbidge RP, Pacey IE, Robinson R, (1998) Statistical aspects of the normal visual field in short-wavelength automated perimetry. Invest Ophthalmol Vis Sci 39: 54-63.
27. Cubbidge RP, Hosking SL, Embleton S, (2002) Statistical modelling of the central 10-degree visual field in short-wavelength automated perimetry. Graefes Arch Clin Exp Ophthalmol 240: 650-657.
28. Bengtsson B, Hellgren KJ, Agardh E, (2008) Test-retest variability for standard automated perimetry and short-wavelength automated perimetry in diabetic patients. Acta Ophthalmol 86: 170-176.
29. Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, et al. (1993) The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 111: 831-836.
30. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, et al. (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39: 367-374.
31. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT, (2003) The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol 121: 519-526.
32. Durand AC, Gould GM, (1910) A method of determining ocular dominance. Journal of the American Medical Association 55: 369-370.
33. Crabb DP, Edgar DF, Fitzke FW, McNaught AI, Wynn HP, (1995) New approach to estimating variability in visual field data using an image processing technique. Br J Ophthalmol 79: 213-217.
34. Conway M, Cubbidge RP, Hosking SL, (2008) Visual field severity indices demonstrate dose-dependent visual loss from vigabatrin therapy. Epilepsia 49: 108-116.
35. Hudson C, Flanagan JG, Turner GS, Chen HC, Young LB, et al. (1998) Short-wavelength sensitive visual field loss in patients with clinically significant diabetic macular oedema. Diabetologia 41: 918-928.
36. Remky A, Arend O, Hendricks S, (2000) Short-wavelength automated perimetry and capillary density in early diabetic maculopathy. Invest Ophthalmol Vis Sci 41: 274-281.
37. Agardh E, Stjernquist H, Heijl A, Bengtsson B, (2006) Visual acuity and perimetry as measures of visual function in diabetic macular oedema. Diabetologia 49: 200-206.
38. Greenstein VC, Hood DC, Ritch R, Steinberger D, Carr RE, (1989) S (blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma. Invest Ophthalmol Vis Sci 30: 1732-1737.
39. Johnson CA, (1994) Selective versus nonselective losses in glaucoma. J Glaucoma 3: S32-44.
40. Hood DC, Benimoff NI, Greenstein VC, (1984) The Response Range of the Blue-Cone Pathways - A Source of Vulnerability to Disease. Invest Ophthalmol Vis Sci 25: 864-867.
41. Hart WM, Burde RM, (1983) 3-Dimensional Topography of the Central Visual-Field - Sparing of Foveal Sensitivity in Macular Disease. Ophthalmology 90: 1028-1038.
42. Swann PG, Loviekitchin JE, (1991) Age-Related Maculopathy.2. the Nature of the Central Visual-Field Loss. Ophthalmic Physiol Opt 11: 59-70.
43. Wild JM, Hudson C, (1995) The Attenuation of Blue-On-Yellow Perimetry by the Macular Pigment. Ophthalmology 102: 911-917.
44. Sample PA, Martinez GA, Weinreb RN, (1994) Short-Wavelength Automated Perimetry Without Lens Density Testing. Am J Ophthalmol 118: 632-641.
45. Anderson AJ, Johnson CA, Werner JS, (2011) Measuring Visual Function in Age-Related Macular Degeneration with Frequency-Doubling (Matrix) Perimetry. Optom Vis Sci 88: 806-815.